Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Financial ResultsItem 2.02 · 8-KLOW RiskNeutral

Elevance Health, Inc.

Filed: Apr 22, 2026CIK: 0001156039
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Elevance Health, Inc. announced its Q1 2026 financial results on April 22, 2026, disclosing revenue, earnings, and other key financial metrics for the quarter ended March 31, 2026. This routine earnings announcement is important for investors to assess the company's operational performance and financial health.

Key Takeaways

Elevance Health released Q1 2026 financial results covering the quarter ended March 31, 2026

The filing includes detailed disclosure of revenue, expenses, and profitability trends

2 more takeaways

Related Filings (3)

3 more filings from Elevance Health, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateApr 22, 2026
Item2.02
CategoryFinancial Results
CIK0001156039
Accession #elv-20260422
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
earnings

What This Means

The company is reporting financial results. Look for revenue trends, profitability changes, and forward guidance.
View Full Filing on SEC.govBrowse More Filings